Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmaceutical Research|October 26, 2006
Fractal michaelis-menten kinetics under steady state conditions: Application to mibefradilRebeccah E Marsh, Jack A Tuszyński
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|November 13, 2009
Continuous model for microtubule dynamics with catastrophe, rescue, and nucleation processesPeter Hinow, Vahid Rezania, Jack A Tuszyński
Chaos (Woodbury, N.Y.)|January 10, 2012
Modeling of relay helix functional dynamics and feasibility of experimental verification by neutron scatteringMiljko V Satarić, Slobodan Zdravković, Jack A Tuszyński
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 7, 2007
Complex movements of motor protein relay helices during the power strokeMiljko V Satarić, Leif Matsson, Jack A Tuszyński
Mathematical Biosciences and Engineering : MBE|January 19, 2016
Algebraic and topological indices of molecular pathway networks in human cancersPeter Hinow, Edward A Rietman, Sara Ibrahim Omar, et al.
Cells|September 9, 2022
Real-Time Monitoring of the Effect of Tumour-Treating Fields on Cell Division Using Live-Cell ImagingHoa T Le, Michael Staelens, Davide Lazzari, et al.
Physical Biology|August 13, 2011
Modeling the effects of drug binding on the dynamic instability of microtubulesPeter Hinow, Vahid Rezania, Manu Lopus, et al.
Mathematical Biosciences and Engineering : MBE|June 3, 2011
A model of competing saturable kinetic processes with application to the pharmacokinetics of the anticancer drug paclitaxelRebeccah E Marsh, Jack A Tuszyński, Michael Sawyer, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 20, 2008
Emergence of power laws in the pharmacokinetics of paclitaxel due to competing saturable processesRebeccah E Marsh, Jack A Tuszyński, Michael B Sawyer, et al.
International Journal of Molecular Sciences|May 2, 2020
Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor DesignMaria Bzówka, Karolina Mitusińska, Agata Raczyńska, et al.
Pageof 2